U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609771) titled 'Heparin to Prevent Organ Failure in Acute Pancreatitis' on May 20.
Brief Summary: This clinical trial is designed to evaluate whether adding a standard blood-thinning medication, Unfractionated Heparin, to standard hospital care can help prevent severe organ failure in patients admitted with acute pancreatitis.
Acute pancreatitis is a sudden and severe inflammation of the pancreas. During this condition, intense inflammation can trigger a hypercoagulable state (excessive blood clotting) in the small blood vessels supplying vital organs. This microvascular clotting can block normal blood flow, starving tissues of oxygen and potential...